SCP
CLB icon

Sandhill Capital Partners’s Core Laboratories CLB Stock Holding History

Sandhill Capital Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,513
Closed -$708K – 69
2015
Q4 		$708K Sell
6,513
-63
-1% -$7.21K 0.23% 33
2015
Q3 		$656K Buy
6,576
+331
+5% +$36K 0.22% 38
2015
Q2 		$712K Buy
6,245
+325
+5% +$39.4K 0.22% 37
2015
Q1 		$619K Buy
+5,920
New +$631K 0.21% 60

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Sandhill Capital Partners's CLB Position: Q1 2016 in Review

Sandhill Capital Partners sold out of Core Laboratories (CLB) in Q1 2016, closing a stake of 6,513 shares — an estimated $708K sold.

Sandhill Capital Partners first reported a position in CLB in Q1 2015 and held it in 4 quarters. The position peaked at $712K in Q2 2015. 365 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

  • Sandhill Capital Partners reported no remaining Core Laboratories position as of Q1 2016 after selling out during the quarter.
  • Sandhill Capital Partners sold 6,513 Core Laboratories shares in Q1 2016, an estimated $708K.
  • Sandhill Capital Partners first reported a position in Core Laboratories in Q1 2015 and held it in 4 quarters.
  • Sandhill Capital Partners's Core Laboratories position peaked at $712K in Q2 2015.
  • 365 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on Sandhill Capital Partners's 13F filing for Q1 2016, filed 9 May 2016.